Antidiabetics Market Report

Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) And Segment Forecasts To 2020

  • Published Date: Jan 2015
  • Report ID: 978-1-68038-304-1
  • Number of Pages: 75
  • Format: Electronic (PDF)
  • Historical Data: 2012-2014

Market Segmentation

  • Global Insulin Product Outlook (Market Revenue in USD Million, 2012 - 2020)
    • Rapid-acting
    • Long-acting
    • Premixed
    • Premixed analog
    • Short-acting
    • Intermediate-acting
  • Global Antidiabetics Product Outlook (Market Revenue in USD Million, 2012 - 2020)
    • Alpha-glucosidase inhibitors
    • Biguanides
    • Sulphonylureas
    • GLP-1 agonist
    • Meglitinides
    • DPP-4 inhibitors
    • SGLT - 2
    • Thiazolidinediones
  • Antidiabetics Regional Outlook (Market Revenue in USD Million, 2012 - 2020)
    • North America
      • North America Insulin Market, by Product
        • Rapid-acting
        • Long-acting
        • Premixed
        • Premixed analog
        • Short-acting
        • Intermediate-acting
      • North America Antidiabetics Market, by Product
        • Alpha-glucosidase inhibitors
        • Biguanides
        • Sulphonylureas
        • GLP-1 agonist
        • Meglitinides
        • DPP-4 inhibitors
        • SGLT - 2
        • Thiazolidinediones
    • Europe
      • Europe Insulin Market, by Product
        • Rapid-acting
        • Long-acting
        • Premixed
        • Premixed analog
        • Short-acting
        • Intermediate-acting
      • Europe Antidiabetics Market, by Product
        • Alpha-glucosidase inhibitors
        • Biguanides
        • Sulphonylureas
        • GLP-1 agonist
        • Meglitinides
        • DPP-4 inhibitors
        • SGLT - 2
        • Thiazolidinediones
    • Asia Pacific
      • Asia Pacific Insulin Market, by Product
        • Rapid-acting
        • Long-acting
        • Premixed
        • Premixed analog
        • Short-acting
        • Intermediate-acting
      • Asia Pacific Antidiabetics Market, by Product
        • Alpha-glucosidase inhibitors
        • Biguanides
        • Sulphonylureas
        • GLP-1 agonist
        • Meglitinides
        • DPP-4 inhibitors
        • SGLT - 2
        • Thiazolidinediones
    • RoW
      • RoW Insulin Market, by Product
        • Rapid-acting
        • Long-acting
        • Premixed
        • Premixed analog
        • Short-acting
        • Intermediate-acting
      • RoW Antidiabetics Market, by Product
        • Alpha-glucosidase inhibitors
        • Biguanides
        • Sulphonylureas
        • GLP-1 agonist
        • Meglitinides
        • DPP-4 inhibitors
        • SGLT - 2
        • Thiazolidinediones

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2012 to 2020
  • Market estimates and forecast for product segments up to 2020
  • Regional market size and forecast for product segments up to 2020
  • Market estimates and forecast for application segments up to 2020
  • Regional market size and forecast for application segments up to 2020
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.